262 related articles for article (PubMed ID: 21228783)
1. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress.
Lopes de Faria JB; Silva KC; Lopes de Faria JM
Hypertens Res; 2011 Apr; 34(4):413-22. PubMed ID: 21228783
[TBL] [Abstract][Full Text] [Related]
2. The concomitance of hypertension and diabetes exacerbating retinopathy: the role of inflammation and oxidative stress.
Duarte DA; Silva KC; Rosales MA; Lopes de Faria JB; Lopes de Faria JM
Curr Clin Pharmacol; 2013 Nov; 8(4):266-77. PubMed ID: 23173956
[TBL] [Abstract][Full Text] [Related]
3. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
[TBL] [Abstract][Full Text] [Related]
5. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
[TBL] [Abstract][Full Text] [Related]
6. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
[TBL] [Abstract][Full Text] [Related]
7. Does hypertension play a role in diabetic retinopathy?
Srivastava BK; Rema M
J Assoc Physicians India; 2005 Sep; 53():803-8. PubMed ID: 16334627
[TBL] [Abstract][Full Text] [Related]
8. Hypertension in insulin-dependent diabetes.
Norgaard K
Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
[TBL] [Abstract][Full Text] [Related]
9. Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes.
Schmechel H; Heinrich U
Diabete Metab; 1993; 19(1 Pt 2):138-42. PubMed ID: 8314417
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
[TBL] [Abstract][Full Text] [Related]
11. Impact of hypertension on prognosis in IDDM.
Hasslacher C; Borgholte G; Ritz E; Wahl P
Diabete Metab; 1989; 15(5 Pt 2):338-42. PubMed ID: 2693153
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure disturbance in diabetes mellitus.
Zanella MT; Freire MB; Milagres R; Ferreira S; Bonomo PP; Kohlmann O; Ribeiro AB
J Hypertens Suppl; 1992 Dec; 10(7):S59-70. PubMed ID: 1291658
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and progression of hypertension in NIDDM and its relationship to IHD and diabetic complications.
Harrower AD
J Hum Hypertens; 1991 Oct; 5(5):463-4. PubMed ID: 1770475
[No Abstract] [Full Text] [Related]
14. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
15. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic microangiopathy].
Standl R
Z Gesamte Inn Med; 1993 Mar; 48(3):140-9. PubMed ID: 8475638
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
[TBL] [Abstract][Full Text] [Related]
18. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and epidemiological aspects of diabetic retinopathy and its relationship with diabetic nephropathy].
Evgrafov VIu; Mamaeva GG; Bishele NA; Liudina LI
Vestn Oftalmol; 1996; 112(1):40-3. PubMed ID: 8659071
[TBL] [Abstract][Full Text] [Related]
20. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Arora MK; Reddy K; Balakumar P
Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
